MELBOURNE, Australia & AUCKLAND, New Zealand & BOULDER, Colo.--(BUSINESS WIRE)--Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today reported that its pipeline product, NeurotrophinCell (NtCell), encapsulated brain choroid plexus cells, may be beneficial in Parkinson’s disease.
